Genome-wide association analysis reveals 12q13.3-q14.1 as new risk locus for sarcoidosis

European Respiratory Journal

Volumn 41, Issue 4, 2013, Pages 888-900

  Hofmann, Sylvia ^a   Fischer, Annegret ^a   Nothnagel, Michael ^a   Jacobs, Gunnar ^a   Schmid, Benjamin ^a   Wittig, Michael ^a   Franke, Andre ^a   Gaede, Karoline I ^a   Schürmann, Manfred ^a   Petrek, Martin ^a   Mrazek, Frantisek ^a   Pabst, Stefan ^a   Grohé, Christian ^a   Grunewald, Johan ^a   Ronninger, Marcus ^a   Eklund, Anders ^a   Rosenstiel, Philip ^a   Höhne, Kerstin ^a   Zissel, Gernot ^a   Müller Quernheim, Joachim ^a   Schreiber, Stefan ^a   more..

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Chronic lung disease; Gene polymorphism; Meta analysis; Risk factors; Sarcoidosis and other granulomatosis; Susceptibility

Indexed keywords

ALLELE; ARTICLE; CHROMOSOME 12Q; CONTROLLED STUDY; CZECH REPUBLIC; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GERMANY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OS9 GENE; PRIORITY JOURNAL; SARCOIDOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN;

CASE-CONTROL STUDIES; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 12; CHRONIC DISEASE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; LUNG DISEASES; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; RNA, MESSENGER; SARCOIDOSIS; SEQUENCE ANALYSIS, DNA;

EID: 84875847895     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00033812     Document Type: Article

References (62)

1. Zissel G, Prasse A, Muller-Quernheim J. Sarcoidosis-immunopathogenetic concepts. Semin Respir Crit Care Med 2007; 28: 3-14.
2. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007; 357: 2153-2165.
3. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999.
4. Am J Respir Crit Care Med 1999; 160: 736-755.
5. Muller-Quernheim J. Sarcoidosis: immunopathogenetic concepts and their clinical application. Eur Respir J 1998; 12: 716-738.
6. Sverrild A, Backer V, Kyvik KO, et al. Heredity in sarcoidosis: a registry-based twin study. Thorax 2008; 63: 894-896.
7. Valentonyte R, Hampe J, Huse K, et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet 2005; 37: 357-364.
8. Li Y, Wollnik B, Pabst S, et al. BTNL2 gene variant and sarcoidosis. Thorax 2006; 61: 273-274.
9. Rybicki BA, Walewski JL, Maliarik MJ, et al. The BTNL2 Gene and Sarcoidosis Susceptibility in African Americans and Whites. Am J Hum Genet 2005; 77: 491-499.
10. Hofmann S, Franke A, Fischer A, et al. Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis. Nat Genet 2008; 40: 1103-1106.
11. Mrazek F, Stahelova A, Kriegova E, et al. Functional variant ANXA11 R230C: true marker of protection and candidate disease modifier in sarcoidosis. Genes Immun 2011; 12: 490-494.
12. Grunewald J, Idali F, Kockum I, et al. Major histocompatibility complex class II transactivator gene polymorphism: associations with Lofgren's syndrome. Tissue Antigens 2010; 76: 96-101.
13. Muller-Quernheim J, Schurmann M, Hofmann S, et al. Genetics of sarcoidosis. Clin Chest Med 2008; 29: 391-414.
14. Hofmann S, Fischer A, Till A, et al. A genome-wide association study reveals evidence of association with sarcoidosis at 6p12.1. Eur Respir J 2011; 38: 1127-1135.
15. Fischer A, Nothnagel M, Franke A, et al. Association of inflammatory bowel disease risk loci with sarcoidosis, and its acute and chronic subphenotypes. Eur Respir J 2011; 37: 610-616.
16. Fischer A, Valentonyte R, Nebel A, et al. Female-specific association of C-C chemokine receptor 5 gene polymorphisms with Lofgren's syndrome. J Mol Med 2008; 86: 553-561.
17. Prasse A, Katic C, Germann M, et al. Phenotyping sarcoidosis from a pulmonary perspective. Am J Respir Crit Care Med 2008; 177: 330-336.
18. Franke A, Fischer A, Nothnagel M, et al. Genome-wide association analysis in sarcoidosis and Crohn's disease unravels a common susceptibility locus on 10p12.2. Gastroenterology 2008; 135: 1207-1215.
19. Klareskog L, Stolt P, Lundberg K, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006; 54: 38-46.
20. Franke A, Balschun T, Sina C, et al. Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL). Nat Genet 2010; 42: 292-294.
21. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575.
22. Abecasis GR, Cookson WOC. GOLD-graphical overview of linkage disequilibrium. Bioinformatics 2000; 16: 182-183.
23. Akaike H. Information Theory and an Extension of the Maximum Likelihood Principle, In: Petran BN, Csaaki F, eds. International Symposium on Information Theory 2nd ed. Budapest: Acadeemiai Kiadi, 1973; pp. 267-281.
24. Schaid DJ, Rowland CM, Tines DE, et al. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002; 70: 425-434.
25. Team RDC. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria 2010. Available from: www.R-project.org
26. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
27. Pearce N. Analytical implications of epidemiological concepts of interaction. Int J Epidemiol 1989; 18: 976-980.
28. Stouffer S, Suchman E, DeVinney L, et al. Studies in Social Psychology in World War II: The American Soldier. Vol. 1, Adjustment During Army Life, Princeton: Princeton University Press, 1949.
29. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000; 132: 365-386.
30. Hampe J, Franke A, Rosenstiel P, et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 2007; 39: 207-211.
31. Wellcome Trust Case Consortium, Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447: 661-678.
32. Dudbridge F, Gusnanto A. Estimation of significance thresholds for genomewide association scans. Genet Epidemiol 2008; 32: 227-234.
33. Xu Z, Taylor J. SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Research 2009; 37: W600-W605.
34. Zissel G, Prasse A, Muller-Quernheim J. Immunologic response of sarcoidosis. Semin Respir Crit Care Med 2010; 31: 390-403.
35. Barton A, Thomson W, Ke X, et al. Re-evaluation of putative rheumatoid arthritis susceptibility genes in the post-genome wide association study era and hypothesis of a key pathway underlying susceptibility. Hum Mol Genet 2008; 17: 2274-2279.
36. Raychaudhuri S, Remmers EF, Lee AT, et al. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet 2008; 40: 1216-1223.
37. Plant D, Flynn E, Mbarek H, et al. Investigation of potential non-HLA rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markers. Ann Rheum Dis 2010; 69: 1548-1553.
38. Fung EY, Smyth DJ, Howson JM, et al. Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus. Genes Immun 2009; 10: 188-191.
39. Cooper JD, Walker NM, Healy BC, et al. Analysis of 55 autoimmune disease and type II diabetes loci: further confirmation of chromosomes 4q27, 12q13.2 and 12q24.13 as type I diabetes loci, and support for a new locus, 12q13.3-q14.1. Genes Immun 2009; 10: Suppl. 1, S95-S120.
40. Bailey R, Cooper JD, Zeitels L, et al. Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes 2007; 56: 2616-2621.
41. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 2009; 41: 824-828.
42. Zhernakova A, Stahl EA, Trynka G, et al. Meta-analysis of genomewide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci. PLoS Genet 2011; 7: e1002004.
43. Liang Y, Ridzon D, Wong L, et al. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 2007; 8: 166.
44. Collison A, Mattes J, Plank M, et al. Inhibition of house dust miteinduced allergic airways disease by antagonism of microRNA-145 is comparable to glucocorticoid treatment. J Allergy Clin Immunol 2011; 128: 160-167.
45. Keller A, Leidinger P, Bauer A, et al. Toward the blood-borne miRNome of human diseases. Nat Methods 2011; 8: 841-843.
46. Kimura Y, Nakazawa M, Tsuchiya N, et al. Genomic organization of the OS-9 gene amplified in human sarcomas. J Biochem 1997; 122: 1190-1195.
47. Hinrichs AS, Karolchik D, Baertsch R, et al. The UCSC Genome Browser Database: update 2006.Nucleic Acids Res 2006; 34: D590-D598.
48. Munro S. The MRH domain suggests a shared ancestry for the mannose 6-phosphate receptors and other N-glycan-recognising proteins. Curr Biol 2001; 11: R499-R501.
49. Christianson JC, Shaler TA, Tyler RE, et al. OS-9 and GRP94 deliver mutant alpha1-antitrypsin to the Hrd1-SEL1L ubiquitin ligase complex for ERAD. Nat Cell Biol 2008; 10: 272-282.
50. Alcock F, Swanton E. Mammalian OS-9 is upregulated in response to endoplasmic reticulum stress and facilitates ubiquitination of misfolded glycoproteins. J Mol Biol 2009; 385: 1032-1042.
51. Wahlstrom J, Dengjel J, Persson B, et al. Identification of HLA-DRbound peptides presented by human bronchoalveolar lavage cells in sarcoidosis. J Clin Invest 2007; 117: 3576-3582.
52. Wahlstrom J, Dengjel J, Winqvist O, et al. Autoimmune T cell responses to antigenic peptides presented by bronchoalveolar lavage cell HLA-DR molecules in sarcoidosis. Clin Immunol 2009; 133: 353-363.
53. Jansen BJ, Eleveld-Trancikova D, Sanecka A, et al. OS9 interacts with DC-STAMP and modulates its intracellular localization in response to TLR ligation. Mol Immunol 2009; 46: 505-515.
54. Zaba LC, Smith GP, Sanchez M, et al. Dendritic cells in the pathogenesis of sarcoidosis. Am J Respir CellMol Biol 2010; 42: 32-39.
55. Kulakova N, Urban B, McMichael AJ, et al. Functional analysis of dendritic cell-T cell interaction in sarcoidosis. Clin Exp Immunol 2010; 159: 82-86.
56. Mathew S, Bauer KL, Fischoeder A, et al. The anergic state in sarcoidosis is associated with diminished dendritic cell function. J Immunol 2008; 181: 746-755.
57. Bordignon M, Rottoli P, Agostini C, et al. Adaptive immune responses in primary cutaneous sarcoidosis. Clin Dev Immunol 2011; 235142.
58. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311: 1770-1773.
59. Zasloff M. Fighting infections with vitamin D. Nat Med 2006; 12: 388-390.
60. Hansdottir S, Monick MM, Hinde SL, et al. Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J Immunol 2008; 181: 7090-7099.
61. Kavathia D, Buckley JD, Rao D, et al. Elevated 1, 25-dihydroxyvitamin D levels are associated with protracted treatment in sarcoidosis. Respir Med 2010; 104: 564-570.
62. Lockstone HE, Sanderson S, Kulakova N, et al. Gene set analysis of lung samples provides insight into pathogenesis of progressive, fibrotic pulmonary sarcoidosis. Am J Respir Crit Care Med 2010; 181: 1367-1375.